Csnk1g3, a member of the casein kinase 1γ subfamily, encodes a protein that likely functions as a kinase within various cellular signaling pathways [1]. Although its exact function is not comprehensively detailed in the provided references, kinases are generally crucial for phosphorylating target proteins, thereby regulating numerous biological processes like cell growth, differentiation, and apoptosis.

In triple-negative breast cancer, the novel curcumin derivative N17 exerts anti-cancer effects through the CSNK1G3/AKT axis. N17 targets the CSNK1G3 protein, inhibits p-AKT(S473), and thereby suppresses cell proliferation, triggers apoptosis, and impedes the epithelial-mesenchymal transition process [2].

In epileptic mice, Jiawei Chaihu Shugan decoction reduces epileptic events by regulating the circRNA-Csnk1g3/Csnk1g3-85aa/CK1γ3/TNF-α signaling pathway, impacting necroptosis and inflammation in hippocampal neurons [3].

In conclusion, Csnk1g3 appears to be involved in cancer-related cell regulation and the modulation of epileptic-related neuronal responses. The findings from these disease-related studies suggest that Csnk1g3 could be a potential target for therapeutic intervention in triple-negative breast cancer and epilepsy, highlighting the importance of understanding its function in these disease conditions.